Russell Investments Group, Ltd. Vir Biotechnology, Inc. Transaction History

Russell Investments Group, Ltd.

$69.8 Billion
Q4 2024

A detailed history of Russell Investments Group, Ltd. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 3,760 shares of VIR stock, worth $34,253. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,760

Previous 20,599 81.75%

Holding current value

$34,253

Previous $154,000 82.47%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$6.74 - $10.17 $113,494 - $171,252	-16,839 Reduced 81.75%	3,760 $27,000
Q3 2024 Nov 13, 2024	SELL	$7.26 - $10.7 $27,362 - $40,328	-3,769 Reduced 15.47%	20,599 $154,000
Q2 2024 Aug 08, 2024	SELL	$7.63 - $12.66 $12,230 - $20,293	-1,603 Reduced 6.17%	24,368 $216,000
Q1 2024 May 08, 2024	BUY	$8.6 - $11.9 $120,236 - $166,373	13,981 Added 116.61%	25,971 $263,000
Q4 2023 Feb 05, 2024	SELL	$7.76 - $10.29 $105,955 - $140,499	-13,654 Reduced 53.24%	11,990 $120,000
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $227,649 - $613,210	24,907 Added 3379.51%	25,644 $240,000
Q2 2023 Aug 10, 2023	SELL	$23.2 - $27.29 $45,541 - $53,570	-1,963 Reduced 72.7%	737 $18,000
Q1 2023 May 09, 2023	SELL	$22.26 - $30.85 $362,838 - $502,855	-16,300 Reduced 85.79%	2,700 $62,000
Q4 2022 Feb 08, 2023	BUY	$19.96 - $28.22 $183,013 - $258,749	9,169 Added 93.27%	19,000 $480,000
Q3 2022 Nov 04, 2022	BUY	$18.26 - $31.1 $51,128 - $87,080	2,800 Added 39.82%	9,831 $186,000
Q2 2022 Jul 29, 2022	SELL	$19.08 - $26.7 $718,133 - $1 Million	-37,638 Reduced 84.26%	7,031 $181,000
Q1 2022 May 05, 2022	BUY	$21.19 - $40.01 $468,871 - $885,301	22,127 Added 98.16%	44,669 $1.15 Million
Q4 2021 Jan 21, 2022	BUY	$30.97 - $54.03 $516,920 - $901,814	16,691 Added 285.27%	22,542 $942,000
Q3 2021 Nov 08, 2021	SELL	$34.9 - $54.54 $737,925 - $1.15 Million	-21,144 Reduced 78.33%	5,851 $253,000
Q2 2021 Aug 04, 2021	SELL	$38.75 - $51.0 $412,106 - $542,385	-10,635 Reduced 28.26%	26,995 $1.28 Million
Q1 2021 May 10, 2021	SELL	$26.34 - $83.07 $225,839 - $712,242	-8,574 Reduced 18.56%	37,630 $1.93 Million
Q4 2020 Feb 08, 2021	BUY	$25.51 - $43.38 $312,089 - $530,710	12,234 Added 36.01%	46,204 $1.24 Million
Q3 2020 Nov 09, 2020	BUY	$28.28 - $53.6 $166,569 - $315,704	5,890 Added 20.98%	33,970 $1.17 Million
Q2 2020 Aug 05, 2020	BUY	$27.89 - $47.86 $783,151 - $1.34 Million	28,080 New	28,080 $1.15 Million

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87.1M

Call Options Held

165K

Put Options Held

1.23M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.21B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Vir Biotechnology, Inc. Transaction History